DUTASTERIDE

SynDRA canonical compound SYN0023312 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	CYP3A5 \| SRD5A1 \| SRD5A2 \| SRD5A3
Mechanism of action	5 alpha reductase inhibitor
Indication	benign prostatic hyperplasia (BPH)
Disease area	urology

All known targets

veltride
avodart
avolve
GG745
GG-745
Dutasterida
Avolve
Duastride
GI-198745
NSC-740477
NSC-759880
Avodart
Dutasteride component of jalyn
Duagen
Dutasteride [USAN]
Avidart (TN)
Avodart (TN)
Avodart, Dutasteride
Avolve (TN)
Duagen (TN)
Duprost (TN)
Dutagen (TN)
Dutas (TN)
GI-198745X
Dutasteride (JAN/USAN/INN)
N-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide
Alpha,alpha,alpha,alpha',alpha',alpha'-Hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide
(1S,3aS,3bS,5aR,9aR,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
(5-alpha,17-beta)-N-{2,5 bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-1-ene-17-carboxamide;dutasteride
(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide
GG 745
JALYN COMPONENT DUTASTERIDE
dutasteride (ep monograph)
GI 198745
NSC 759880
dutasteride (usp-rs)
dutasteride (usp monograph)